Oruka therapeutics, inc.ORKA.US Overview

US StockHealthcare

(No presentation for ORKA)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

ORKA Overall Performance

ORKA AI Analysis & Strategy

ORKA Recent Performance

1.70%

Oruka therapeutics, inc.

1.30%

Avg of Sector

0.61%

S&P500

ORKA PowerScanner

ORKA Key Information

ORKA Valuation Metrics

ORKA Earnings Table

ORKA Profile

Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.